Tag: Photoimmunotherapy | Page 6

ML7710 for photoimmunotherapy against regulatory T cells in tumors

Application Note / cancer, customer, in vivo, Kill cancer, ML7710, Modulight in science, National Cancer Institute, National Institutes of Health, NCI, NIH, oncology, Photoimmunotherapy / June 14, 2021

Results Tumor growth was significantly suppressed by photoimmunotherapy, compared to control or IgG without light activation. Tumor growth suppression, as well as overall survival after photoimmunotherapy, were significantly better with F(ab´)2 fragments than with full IgG. This efficacy improvement might be related to killer T cells, which were detected in much higher numbers

ML7710 for photoimmunotherapy against regulatory T cells in tumors Read More »

Rapid Depletion of Intratumoral Regulatory T cells Induces Synchronized CD8 T and NK Cell Activation and IFN-γ-dependent Tumor Vessel Regression

Scientific papers / 690 nm, H&N cancer, head & neck cancer, in vivo, IR700, ML7710, Photoimmunotherapy, targeted photoimmunotherapy, tumor / June 1, 2021

Published in: Cancer Research Authors: Yutaka Kurebayashi, Colleen P. Olkowski, Kelly C. Lane, Olga V. Vasalatiy, Biying C. Xu, Ryuhei Okada, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi, Noriko Sato

Rapid Depletion of Intratumoral Regulatory T cells Induces Synchronized CD8 T and NK Cell Activation and IFN-γ-dependent Tumor Vessel Regression Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – May 2021

Laser-sharp Research / Kill cancer, laser-sharp research, lasers in science, ML7710, Modulight in science, Photoimmunotherapy / June 1, 2021

Modulight Spotlights: LASER-SHARP RESEARCH – May 2021 The renowned pioneer in photoimmunotherapy (PIT), Professor Hisataka Kobayashi, has published an outstanding article with his team at National Cancer Institute / NIH. The article is about improving the antitumor efficacy of near-infrared photoimmunotherapy (NIR-PIT) by simultaneous targeting of cancer cells and regulatory T cells in the tumor

Modulight Spotlights: LASER-SHARP RESEARCH – May 2021 Read More »

ML7710 Clinical Multi-indication Laser Platform

onepager, product pages / biomedical, cancer, certification, laser platform, laser system, medical, medical laser, ML7710, multi-indication, multichannel, oncology, PDT, Photodynamic therapy, Photoimmunotherapy, photothermal therapy, PIT, PTT, tumor treatment / June 18, 2014

ML7710 - Medical Laser Platform for Clinical UseML7710 is a cloud-connected multichannel, multi-indication laser platform widely used in oncology and surgical applications. It supports all commercial photosensitizers and offers tailored treatment flows for different indications. Automated calibration and advanced analytics further enhance safety, reliability, and patient comfort.Perfect laser for oncology and other clinical applications ML7710

ML7710 Clinical Multi-indication Laser Platform Read More »